Cargando…

miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2

microRNAs (miRNAs) have been hypothesized to function as oncogenes or tumor suppressors by targeting specific cancer-related genes. Previous studies have reported that miR-223 may serve as a tumor suppressor in a number of cancer types, however, knowledge of its targets in non-small cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	NIAN, WEIQI, AO, XUJUN, WU, YONGZHONG, HUANG, YI, SHAO, JIANGHE, WANG, YIMING, CHEN, ZHENGTANG, CHEN, FANGLIN, WANG, DONGLIN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789020/ https://www.ncbi.nlm.nih.gov/pubmed/24137330 http://dx.doi.org/10.3892/ol.2013.1375

Ejemplares similares

Sensitivity of non-small cell lung cancer to erlotinib is regulated by the Notch/miR-223/FBXW7 pathway
por: Zhang, Haiwei, et al.
Publicado: (2017)

Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells
por: Li, Luchun, et al.
Publicado: (2017)

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2019)

Nanocomplex of Berberine with C(60) Fullerene Is a Potent Suppressor of Lewis Lung Carcinoma Cells Invasion In Vitro and Metastatic Activity In Vivo
por: Horak, Iryna, et al.
Publicado: (2021)

MicroRNA-223 Expression Is Upregulated in Insulin Resistant Human Adipose Tissue
por: Chuang, Tung-Yueh, et al.
Publicado: (2015)

PIMT is a novel and potent suppressor of endothelial activation
por: Zhang, Chen, et al.
Publicado: (2023)

Cyclin D activates the Rb tumor suppressor by mono-phosphorylation
por: Narasimha, Anil M, et al.
Publicado: (2014)

MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop
por: Luo, Peng, et al.
Publicado: (2019)

Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer
por: Chen, Xiu-Xiu, et al.
Publicado: (2015)

Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE(2) production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activity
por: Duan, Yuzhong, et al.
Publicado: (2014)

miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
por: HAN, JING, et al.
Publicado: (2016)

Auranofin is a potent suppressor of osteosarcoma metastasis
por: Topkas, Eleni, et al.
Publicado: (2015)

MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways
por: Cui, Shi-Yun, et al.
Publicado: (2014)

MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3
por: Liang, Hongwei, et al.
Publicado: (2015)

Increase of circulating miR-223 and insulin-like growth factor-1 is associated with the pathogenesis of acute ischemic stroke in patients
por: Wang, Yang, et al.
Publicado: (2014)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

Ultraconserved element uc.333 increases insulin sensitivity by binding to miR-223
por: Zhang, Yang, et al.
Publicado: (2020)

A novel tumour suppressor lncRNA F630028O10Rik inhibits lung cancer angiogenesis by regulating miR‐223‐3p
por: Qin, Limei, et al.
Publicado: (2020)

Efficacy of Cyclin Dependent Kinase 4 Inhibitors as Potent Neuroprotective Agents against Insults Relevant to Alzheimer’s Disease
por: Sanphui, Priyankar, et al.
Publicado: (2013)

Cyclin-dependent kinase 6 (CDK6) as a potent regulator of the ovarian primordial-to-primary follicle transition
por: Ataei-Nazari, S., et al.
Publicado: (2022)

A Novel Bispecific Antibody Targeting CD3 and Lewis Y with Potent Therapeutic Efficacy against Gastric Cancer
por: Chen, Jie, et al.
Publicado: (2021)

Smad4 (DPC4)--a potent tumour suppressor?
por: Duff, E. K., et al.
Publicado: (1998)

Kalkitoxin: A Potent Suppressor of Distant Breast Cancer Metastasis
por: Shrestha, Saroj Kumar, et al.
Publicado: (2023)

Cyclin genes as potential novel prognostic biomarkers and therapeutic targets in breast cancer
por: Liu, Nian-Qiu, et al.
Publicado: (2022)

miR-223: An Immune Regulator in Infectious Disorders
por: Yuan, Shun, et al.
Publicado: (2021)

miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor
por: ZHAO, FENG-YI, et al.
Publicado: (2016)

Selective repression of the oncogene cyclin D1 by the tumor suppressor miR-206 in cancers
por: Elliman, S J, et al.
Publicado: (2014)

Transcriptional Regulation by Nuclear Corepressors and PGC-1α: Implications for Mitochondrial Quality Control and Insulin Sensitivity
por: Qi, Zhengtang, et al.
Publicado: (2012)

[(223)Ra] RaCl(2) nanomicelles showed potent effect against osteosarcoma: targeted alpha therapy in the nanotechnology era
por: Yang, Yang, et al.
Publicado: (2022)

Oxoisoaporphine as Potent Telomerase Inhibitor
por: Wei, Zu-Zhuang, et al.
Publicado: (2016)

MicroRNA expression profiles of granulocytic myeloid-derived suppressor cells from mice bearing Lewis lung carcinoma
por: Jiang, Jingwei, et al.
Publicado: (2016)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Tumor suppressor role of microRNA-545 in oral squamous cell carcinoma
por: Yuan, Guangyi, et al.
Publicado: (2019)

Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors
por: Brisse, Morgan E., et al.
Publicado: (2019)

The nuclear structure of $^{223}$Fr
por: Kurcewicz, W, et al.
Publicado: (1991)

MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer
por: Kapora, Elena, et al.
Publicado: (2019)

The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia
por: Mansour, Marc R., et al.
Publicado: (2013)

The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations
por: Feng, Yongdong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_si2hlv38boeke57tt33m6dcioj